Skip to content
Screener

CeriBell, Inc. CBLL Price / book

Price / book at other companies

IAR
Integra LifeSciencesIART
1.3×+0.5×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
14.3×-2.1×
iRadimed logo
iRadimedIRMD
12.5×+5.1×
Teladoc Health logo
Teladoc HealthTDOC
1.2×+0.2×
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc.IRTC
21×-26.3×
ICU Medical logo
ICU MedicalICUI
1.7×+0.2×

Other financials

Income statement

See full
Revenue$28.1M+32.5%
Gross profit$25.9M+38.8%
Operating income-$20.0M-33.6%
Net income-$19.3M-41.2%
EPS (diluted)-$0.51-34.2%

Balance sheet

See full
Cash & equivalents$32.7M-18.6%
Total debt$21.9M+1.7%
Total equity$128.3M-25.5%
Total assets$166.3M-19.9%

Cash flow

See full
Operating cash flow-$12.9M-70.8%
CapEx$17.0K-76.1%
Free cash flow-$12.9M-69.4%

Valuation

See full
Market cap$713.7M+50.8%
Enterprise value$702.95M+54.6%
P/S7×+0.9×

Profitability

See full
Gross margin88.9%+1.1pp
Operating margin-68.6%+1.5pp
Net margin-64.7%+0.9pp
FCF margin-53.7%+4.4pp

Returns & leverage

See full
Return on equity-43.9%—
Debt / equity0.2×0.0×
Current ratio9.2×-4.1×

Where this comes from

Calculated from CeriBell, Inc.’s reported figures.

market cap/total stockholders equity=5.8×

Based on the most recent quarter.

The source filing: CeriBell, Inc.’s 10-Q, filed August 10, 2026. Open the filing →

Filed
Aug 10, 2026, 4:50 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-342574

FAQ

What is CeriBell, Inc.'s price / book?
CeriBell, Inc. (CBLL) reported price / book of 5.8× in Q2 2026.
How has CeriBell, Inc.'s price / book changed year-over-year?
CeriBell, Inc.'s price / book increased by 39.4% year-over-year, from 4.1× to 5.8×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about CeriBell, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude